4SC AG P/E Adelante
¿Qué es el P/E Adelante de 4SC AG?
El P/E Adelante de 4SC AG es -2.94
¿Cuál es la definición de P/E Adelante?
La relación precio a futuro es la relación entre el precio de las acciones de una empresa y las ganancias por acción estimadas de la compañía para los próximos doce meses.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
P/E Adelante de compañías en Sector Health Care en XETRA en comparadas con 4SC AG
¿Qué hace 4SC AG?
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.
Empresas con p/e adelante similar a 4SC AG
- BioCardia tiene P/E Adelante de -3.04
- BioCardia tiene P/E Adelante de -3.04
- BioCardia tiene P/E Adelante de -3.04
- BioCardia tiene P/E Adelante de -3.04
- Rewalk Robotics Ltd tiene P/E Adelante de -3.02
- Workhorse Inc tiene P/E Adelante de -3.02
- 4SC AG tiene P/E Adelante de -2.94
- Altimmune Inc tiene P/E Adelante de -2.93
- Codexis tiene P/E Adelante de -2.86
- Co-Diagnostics Inc tiene P/E Adelante de -2.85
- Brookdale Senior Living Inc tiene P/E Adelante de -2.83
- Ocugen Inc tiene P/E Adelante de -2.77
- IMAC Inc tiene P/E Adelante de -2.77